Advertisement Pharmaceutical Business review - Page 600 of 5279 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
June 26, 2026

Ionis grants Recordati rights to zilganersen for Alexander disease

Ionis Pharmaceuticals has entered a licence agreement granting global pharmaceutical company Recordati exclusive rights to develop and commercialise zilganersen to treat Alexander disease (AxD) in countries outside the US.

Continue
Ionis will receive a $30m upfront payment as part of the deal. Credit: Piotr Swat / Shutterstock.com.
June 26, 2026

Immunai and Boehringer partner to identify T-cell targets

Confirmed findings will move to Immunai’s lab, possibly serving as foundations for new Boehringer Ingelheim drug discovery projects. Credit: nitpicker / Shutterstock.com.
June 25, 2026

MSD’s Keytruda-Padcev combo secures EC approval for MIBC

The authorisation applies to adults with resectable MIBC who cannot be treated with cisplatin-based chemotherapy. Credit: Antonio Marca / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. RQ Bio secures $115m to develop influenza antibody programme
  2. Boehringer and Combotope partner for cancer antibodies
  3. Haisco and Nuvectis sign licensing deal for two drugs
  4. Genprex’s Reqorsa combo secures Canadian patent for lung cancer
  5. Lilly and BioArctic sign deal to develop neurodegenerative therapy

PRESS RELEASES

Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci
Dr Imre Molnár Honoured With Tswett-Nernst European Award
Dr Imre Molnár Honoured With Tswett-Nernst European Award
DryLab® Automation Extended to Agilent OpenLab CDS System
DryLab® Automation Extended to Agilent OpenLab CDS System

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography